Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection.
Saved in:
| Title: | Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. |
|---|---|
| Authors: | Beccari MV; State University of New York Upstate University Hospital, Syracuse, New York, USA., Mogle BT; State University of New York Upstate University Hospital, Syracuse, New York, USA., Sidman EF; State University of New York Upstate University Hospital, Syracuse, New York, USA.; State University of New York Upstate Medical University, Syracuse, New York, USA., Mastro KA; Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA., Asiago-Reddy E; State University of New York Upstate Medical University, Syracuse, New York, USA., Kufel WD; State University of New York Upstate University Hospital, Syracuse, New York, USA wkufel@binghamton.edu.; State University of New York Upstate Medical University, Syracuse, New York, USA.; Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 May 24; Vol. 63 (6). Date of Electronic Publication: 2019 May 24 (Print Publication: 2019). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
